Search Results 3381-3390 of 23785 for menopause

  1. Chemoradiation With or Without Atezolizumab in Treating Patients With Limited Stage Small Cell Lung Cancer - Mayo Clinic

    Negative serum pregnancy test within 14 days of registration for pre-menopausal women of childbearing potential. The patient or a legally authorized ...

  2. Study Evaluating the Safety, Tolerability, and Effectiveness of EDP-305 in Subjects with Nonalcoholic Steatohepatitis (NASH) - Mayo Clinic

    is post-menopausal (a demonstration of a total cessation of menses for ≥1 year with a follicle stimulating hormone (FSH) level of >35 mIU/mL). All male ...

  3. Breast cancer - Doctors and departments - Mayo Clinic

    Hines, M.D.. Internist. Phoenix, AZ. Areas of focus: Osteoporosis, Breast cancer, Menopause, BRCA gene mutation. Timothy J. Hobday, M.D..

  4. A Study To Investigate Efficacy & Safety Of Intratumoral INT230-6 Compared To US Standard Of Care In Adults With Soft Tissue Sarcomas (INVINCIBLE-3) - Mayo Clinic

    ... menopausal, as defined by 12 months of spontaneous amenorrhea with an appropriate clinical profile, e.g., age appropriate, \> 45 years, in the absence of ...

  5. Breast cancer - Doctors and departments - Mayo Clinic

    Breast imaging, Breast cancer, Menopause, Fibrocystic breast disease. Research. Doctors discussing imaging test results. Mayo Clinic doctors and scientists are ...

  6. Surgery - Doctors - Mayo Clinic

    ... Menopause, Vaginal yeast infection, Heavy menstrual bleeding, Uterine polyps, Uterine fibroid, Cervical dysplasia, Sexually transmitted disease ...

  7. Overactive bladder - Symptoms and causes - Mayo Clinic

    Hormonal changes during menopause. Urinary tract infections, which can cause symptoms like those of an overactive bladder. Overactive bladder symptoms also ...

  8. A Study to Compare the Effectiveness, Safety and Tolerability of P1101 vs. Anagrelide for Essential Thrombocythemia - Mayo Clinic

    onset of menopause, must agree to use an acceptable form of birth control until 28 days following the last dose of the study drug, and females must agree to ...

  9. REcycled CartiLage Auto/Allo IMplantation - Mayo Clinic

    Females of childbearing potential are defined as premenopausal and not surgically sterilized, or post-menopausal for fewer than 2 years. A urine pregnancy ...

  10. TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement Study - Mayo Clinic

    Women of childbearing potential (including those with an onset of menopause < 2 years prior to Screening, non-therapy-induced amenorrhea for < 12 months ...